Enhanced Delivery Epinephrine Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,191,737 | Enhanced Delivery Epinephrine Compositions In force · High confidence UsedRemaining | Aquestive Therapeutics, Inc. | In force | High confidence | ||
| US 12,023,309 | Enhanced Delivery Epinephrine Compositions Term ended Term ended Apr 26, 2021 · High confidence | Aquestive Therapeutics, Inc. | Term ended | Term ended Apr 26, 2021 | High confidence | |
| US 12,427,121 | Enhanced Delivery Epinephrine Compositions Term ended Term ended Apr 26, 2021 · High confidence | Aquestive Therapeutics, Inc. | Term ended | Term ended Apr 26, 2021 | High confidence | |
| US 12,433,850 | Enhanced Delivery Epinephrine and Prodrug Compositions Term ended Term ended Apr 26, 2021 · High confidence | Aquestive Therapeutics, Inc. | Term ended | Term ended Apr 26, 2021 | High confidence | |
| Application 15/717,859 | Enhanced Delivery Epinephrine Compositions Abandoned Abandoned Mar 2, 2018 | Aquestive Therapeutics, Inc. | Abandoned | Abandoned Mar 2, 2018 | ||
| Application 17/514,805 | Enhanced Delivery Epinephrine Compositions Abandoned Abandoned Jun 10, 2022 | Aquestive Therapeutics, Inc. | Abandoned | Abandoned Jun 10, 2022 | ||
| Application 17/549,219 | Enhanced Delivery Epinephrine and Prodrug Compositions Pending Not granted | Aquestive Therapeutics, Inc. | Pending | Not granted | ||
| Application 18/413,556 | Enhanced Delivery Epinephrine and Prodrug Compositions Pending Not granted | Aquestive Therapeutics, Inc. | Pending | Not granted |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Aquestive Therapeutics, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.